Apollo HealthCo reports positive PAT of Rs 32 Crores vs Rs (28) Crores of PAT Loss in Q3 FY24  

Q3 Consolidated Revenues grew 14% YoY to Rs 5,527 Crores 

Q3 Consolidated EBITDA grew 24% YoY to Rs 762 Crores 

Q3 Consolidated PAT grew 52% YoY to Rs 372 Crores  

On track to add 3,512 beds over a period of 3 to 4 years, beginning FY26 

Apollo Hospitals achieved a milestone in cardiac care, completing over 1000 robotic cardiac surgeries across Bangalore & Chennai 

Apollo Hospitals partnered with Microsoft to advance healthcare through AI and digital innovation focussing on disease progression, and genomics 

Apollo Hospitals declares an Interim Dividend of Rs 9 per share

Dr. Prathap C Reddy, Chairman, Apollo Hospitals Enterprise Ltd. said,

“At Apollo Hospitals, we have always measured success by the lives we touch and the impact we create for a healthier nation. With Q3 FY25 revenues rising by 14% to ₹ 5,527 crores and EBITDA by 24% to ₹ 762 crores, our performance is a testament to our commitment of a healthier India by bringing cutting-edge technologies to everyone who needs it. We are on track to add 3,512 beds across 11 locations over 3 to 4 years beginning FY26. The results reflect our growth story that underlines our purpose of healing India and touching more than a billion lives. From Mumbai to Varanasi and Chennai to Gurugram, we are committed to ensuring that quality healthcare is not a privilege but a fundamental right for all.

Our strategic partnership with Microsoft is accelerating our AI-driven healthcare transformation, including innovation in disease progression, and genomics. By collaborating with the University of Leicester, we are equipping the next generation of healthcare professionals with unmatched skills. Taking our impact global, Apollo Hospitals Enterprise Limited (AHEL) signed a landmark Memorandum of Understanding (MoU) with Mayapada Healthcare Group, Indonesia to transform the region’s healthcare landscape by enhancing medical capabilities, clinical programs, and operational excellence in oncology, cardiology, neurology, and transplant surgery.

At Apollo Hospitals, we recognise the rising burden of cancer and launched Unify to Notify campaign towards classifying cancer as a notifiable disease. Our pursuit of enhancing our clinical excellence continues with landmark surgeries and treatments at our hospitals across India. Apollo Hospitals, Chennai achieved a remarkable benchmark in cardiac care by completing 500 robotic cardiac surgeries. Apollo Hospitals, Bangalore performed a robotic knee replacement surgery on a 17-year-old boy, the youngest reported case in the world, who was struggling with severe Avascular Necrosis.

As we look ahead, we are confident about our plans to creat a sustainable impact and value to ‘Heal in India’ and ‘Heal by India’ with world-class healthcare and cutting-edge innovation not just for India but for the world.” 

Q3 FY25 CONSOLIDATED RESULTS

REVENUE

Q3 FY25 Revenues grew to Rs. 5,527 Crores; 14% YoY growth

• Healthcare Services (HCS) Revenue at Rs. 2,785 Crore; 13% YoY growth
• AHLL: Revenues at Rs. 390 Crores; 15% YoY growth
• Apollo HealthCo: Pharmacy Distribution & Digital Health Revenues at Rs. 2,352 Crores; 15% YoY growth
• GMV of Apollo 24/7 at Rs. 760 Crores

EBITDA

Q3 FY25 Consolidated EBITDA stood at Rs. 762 Crores; 24% YoY growth

• Healthcare Services (HCS) EBITDA at Rs. 671 Crores; YoY growth of 14%
• AHLL EBITDA at Rs. 34 Crores; YoY growth of 32%
• Apollo HealthCo: Pharmacy distribution & Digital health EBITDA at Rs. 57 Crores 

PAT

Q3 FY25 Consolidated PAT Rs. 372 Crores, compared to Rs. 245 Crores in Q3 FY24; 52% YoY growth

• Healthcare Services (HCS) PAT at Rs. 348 Crore; YoY growth of 21%

YTD Dec FY25 CONSOLIDATED RESULTS 

REVENUE 

YTD Dec FY25 Revenues grew to Rs. 16,202 Crores; 15% YoY growth

• Healthcare Services (HCS) Revenue at Rs. 8,326 Crores; 14% YoY growth
• AHLL: Revenues at Rs. 1,160 Crores; 15% YoY growth
• Apollo HealthCo: Pharmacy Distribution & Digital Health Revenues at Rs. 6,717 Crores; 16% YoY growth
• GMV of Apollo 24/7 at Rs. 2,212 Crores

EBITDA 

YTD Dec FY25 Consolidated EBITDA stood at Rs. 2,252 Crores; 29% YoY growth

• Healthcare Services (HCS) EBITDA at Rs. 2,014 Crores; YoY growth of 14%
• AHLL EBITDA at Rs. 107 Crores; YoY growth of 32%
• Apollo HealthCo: Pharmacy distribution & Digital health EBITDA at Rs. 131 Crores

PAT

YTD Dec FY25 Consolidated PAT Rs. 1,056 Crores, compared to Rs. 645 Crores in YTD Dec FY24; 64% YoY growth

• Healthcare Services (HCS) PAT at Rs. 1,041 Crore; YoY growth of 20%

Financial Performance – Q3 FY25

Consolidated Q3 FY25 Performance 

o    Revenues at Rs.55,269 mn vs Rs.48,506 mn in Q3 FY24; growth of 14% YoY

o    EBITDA at Rs.7,615 mn vs Rs.6,137 mn in Q3 FY24. This is after Apollo 24/7 cost of Rs 1,405 mn in the quarter (including Rs 268 mn non-cash ESOP charge) vs Rs 1,557 mn in Q3 FY24.

o    Reported PAT at Rs.3,723 mn vs Rs.2,453 mn in Q3 FY24

o    Diluted EPS of Rs.25.89 per share in Q3 FY25 (not annualized) 

Healthcare service Q3 FY25 Performance 

o    Revenue at Rs.27,850 mn vs Rs 24,635 mn in Q3 FY24; growth of 13% YoY

o    EBITDA grew by 14% at Rs.6,706 mn vs Rs.5,860 mn in Q3 FY24; Margins at 24.1% in Q3 FY25

o    PAT stood at Rs.3,483 mn vs Rs.2,872 mn in Q3 FY24, 21% growth

Apollo Health and Lifestyle Limited Q3 FY25 Performance 

o    Revenue at Rs. 3,895 mn vs Rs.3,377 mn in Q3 FY24; growth of 15% YoY

o    EBITDA grew by 32% at Rs.342 mn vs Rs. 259 mn in Q3 FY24; Margins at 8.8% in Q3 FY25

o    PAT loss of Rs.80 mn vs loss of Rs.143 mn in Q3 FY24

Apollo HealthCo Q3 FY25 Performance   

o    Revenue at Rs.23,524 mn vs Rs.20,493 mn in Q3 FY24; growth of 15% YoY

o    EBITDA at Rs.566 mn vs Rs.19 mn in Q3 FY24; Margins at 2.4% in Q3 FY25

o    PAT stood at Rs.321 mn vs loss of Rs.276 mn in Q3 FY24

Financial Performance – YTD Dec FY25

Consolidated YTD Dec FY25 Performance 

o    Revenues at Rs. 162,018 mn vs Rs. 141,153 mn in YTD Dec FY24; growth of 15% YoY

o    EBITDA at Rs.22,521 mn vs Rs. 17,502 mn in YTD Dec FY24. This is after Apollo 24/7 cost of Rs 4,255 mn (including Rs 621 mn non-cash ESOP charge) vs Rs. 5,569 mn in YTD Dec FY24.

o    Reported PAT at Rs.10,563 mn vs Rs. 6,448 mn in YTD Dec FY24.

o    Diluted EPS of Rs. 73.46 per share in YTD Dec FY25 (not annualized) 

Healthcare service YTD Dec FY25 Performance 

o    Revenue at Rs. 83,255 mn vs Rs. 73,045 mn in YTD Dec FY24; growth of 14% YoY

o    EBITDA grew by 14% at Rs.20,144 mn vs Rs. 17,627 mn in YTD Dec FY24; Margins at 24.2% in YTD Dec FY25

o    PAT stood at Rs. 10,409 mn vs Rs. 8,648 mn in YTD Dec FY24, 20% growth

Apollo Health and Lifestyle Limited YTD Dec FY25 Performance 

o    Revenue at Rs. 11,596 mn vs Rs.10,107 mn in YTD Dec FY24; growth of 15% YoY

o    EBITDA grew by 32% at Rs.1,065 mn vs Rs.809 mn in YTD Dec FY24; Margins at 9.2% in YTD Dec FY25

o    PAT loss of Rs.228 mn vs loss of Rs.420 mn in YTD Dec FY24

Apollo HealthCo YTD Dec FY25 Performance 

o    Revenue at Rs.67,167 mn vs Rs.58,002 mn in YTD Dec FY24; growth of 16% YoY

o    EBITDA at Rs.1,312 mn vs loss of Rs.934 mn in YTD Dec FY24; Margins at 2.0 % in YTD Dec FY25

o    PAT stood at Rs.382 mn vs loss of Rs.1,779 mn in YTD Dec FY24

Q3 FY25 Segment-wise Performance Update 

Healthcare Services (Hospitals) 

As on December 31, 2024, Apollo Hospitals had 7,996 operating beds across the network (excluding AHLL & managed beds). The overall occupancy for hospitals was at 68% vs 66% in the same period in the previous year, aided by a strong increase in patient flows across hospitals. 

Consolidated Revenues of the healthcare services division increased by 13% to Rs.27,850 million in Q3 FY25 compared to Rs.24,636 million in Q3 FY24.

EBITDA (Post Ind AS 116) was at Rs.6,706 million in Q3 FY25 compared to Rs. 5,860 million in Q3 FY24. EBITDA was higher by 14 % YoY.

Revenues in the Tamil Nadu cluster grew by 8%. ARPOB grew by 11% to Rs. 77,084. Overall occupancy in the cluster was 1,305 beds (64% occupancy) as compared to 1,341 beds (66% occupancy) in the previous year.

In AP Telangana region, Revenues grew by 24%, IP volumes grew by 15%. ARPOB grew by 9% to Rs.63,013. Occupancy in the cluster was 815 beds (66% occupancy) as compared to 718 beds (57% occupancy) in the previous year.

In Karnataka region, Revenues grew by 17%, IP volumes grew by 5%. ARPOB grew by 6% to Rs.65,513. Occupancy in the cluster was 549 beds (71% occupancy) as compared to 501 beds (67% occupancy) in the previous year.

In Eastern region, Revenues grew by 8%, IP volumes grew by 5%. ARPOB grew by 6% to Rs.46,485. Occupancy in the cluster was 1,349 beds (72% occupancy) as compared to 1,321 beds (73% occupancy) in the previous year.

In Western region, Revenues grew by 12%, IP volumes degrew by 2%. ARPOB grew by 9% to Rs.51,325. Occupancy in the cluster was 499 beds (57% occupancy) as compared to 487 beds (57% occupancy) in the previous year.

In Northern region, Revenues grew by 11%, IP volumes grew by 10%. ARPOB grew by 4% to Rs.60,219. Occupancy in the cluster was 885 beds (74% occupancy) as compared to 833 beds (70% occupancy) in the previous year.

Apollo Health and Lifestyle Limited: Diagnostics and Retail Healthcare 

• AHLL Gross Revenue at Rs.3,895 million; 15% YoY growth
• Diagnostics Revenue stood at Rs.1,212 million and Spectra at Rs.681 million

Apollo HealthCo: Digital Healthcare and Omni-channel Pharmacy platform 

• Offline Pharmacy distribution revenues at Rs. 20,786 million in Q3 FY25 while Revenues from Digital platform were at Rs. 2,738 million
• Overall Health Co Revenues were at Rs 23,524 million representing 15% YoY growth.
• 132 net new stores were opened in this quarter, taking the total number to 6,360 stores.
• GMV of Apollo 24/7 at Rs 7,599 million in Q3 FY25, growth of 11% over Q3 FY24.
• Avg Q3 FY25 run rate of 75K/day order across Pharma, Diagnostics Consultations (including IP/OP referrals) compared to 61K/day in Q3 FY24.

CLINICAL EXCELLENCE HIGHLIGHTS

• Apollo Hospitals, Chennai achieved a remarkable milestone in cardiac care, completing 500 robotic cardiac surgeries.
• Apollo Hospitals, Chennai performed India’s first implantation using the new-generation Allegra Transcatheter Aortic Valve Implantation (TAVI) system for a 78-year-old patient who had undergone valve replacement surgery.
• Apollo Hospitals, Bangalore performed a robotic knee replacement surgery on a 17-year-old boy, the youngest reported case in the world, who was struggling with knee pain due to severe Avascular Necrosis.
• Apollo Jubilee Hills, Hyderabad performed a record of 25 complex Asleep Deep Brain Stimulation surgeries in 24 days.
• Apollo Kolkata treated a 60-year-old male patient with rare and complex kidney condition, malignancy in a cross-fused ectopic kidney using robotic-assisted surgery. This was the first-of-its-kind procedure in India.

NEW LAUNCHES, INITIATIVES AND PARTNERSHIPS

• Apollo Hospitals Ahmedabad launched state’s first FemRejuvenate Therapy designed to rejuvenate vaginal health and enhance long-term intimacy, wellness, and confidence in women.
• Apollo Cancer Centers leads Breast Cancer Awareness with “Pedal Pink” Cyclothon in Tiruvallur.
• Apollo Hospitals Hyderabad launched the Multidisciplinary Centre for Foot & Ankle Care to address critical complications like diabetic neuropathy and limb deformities.
• Unify to Notify campaign was launched to classify cancer as a notifiable disease.

The post Apollo Hospitals announces strong Q3 FY25 results  appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

The company’s total income rose to Rs 14,286.91 crore in the reporting quarter from Rs 12,071.54 crore in the year-ago period. Total expenses stood at Rs 9,105.94 crore in the latest December quarter as against Rs 7,899.85 crore a year earlier.

The board of the company also approved a third interim dividend of Rs 4.30 per share for the financial year 2024-25.The interim dividend shall be paid on or before March 6, 2025 to shareholders.

 Operational and Financial Highlights: Q3 FY25 vs Q3 FY24 (Standalone) 

• Q3 Net Profit grows ₹4,029 crore, up by 23%

• Market capitalization grows ₹1,31,844 crore, up by 21%

• Asset Under Management (AUM) grows to ₹65 lakh crore

• 3rd interim dividend of ₹30 per equity share (on face value of ₹10/- each)

• Net interest income: ₹4,930 crore Vs ₹4,153 crore, up by 19%

• Net credit-impaired assets reduced to 0.74% from 0.82%

• Revenue from operations: ₹14,157 crore Vs ₹11,982 crore, up by 18%

• Disbursements: ₹54,692 crore Vs ₹46,358 crore, up by 18%

• Total income: ₹14,173 crore Vs ₹12,000 crore, up by 18%

• Average cost of funds: 7.18% Vs 7.28%, reduction by 10 bps

• Spread: 2.95% Vs 2.85%, up by 10 bps

• Net interest margin: 3.66% Vs 3.61%, up by 5 bps

Operational and Financial Highlights: 9M FY25 vs 9M FY24 (Standalone) 

• Net Profit: ₹11,477 crore Vs ₹10,003 crore, up by 15%

• Net interest income: ₹14,191 crore Vs ₹11,422 crore, up by 24%

• Revenue from operations: ₹40,752 crore Vs ₹34,533 crore, up by 18%

• Disbursements: ₹1,45,647 crore Vs ₹1,22,089 crore, up by 19%, of which disbursements to renewables constituted:

• ₹17,612 crore Vs ₹9,858 crore, i.e. with YoY increase of 79%

• Total income: ₹40,805 crore Vs ₹34,571 crore, up by18%

• Spread: 2.94% Vs 2.82%, up by 12 bps

• Net interest margin: 3.64% Vs 3.52%, up by 12 bps

• Return on net worth: 21.07%

The post REC Net Profit grow up 23% to ₹4,029 crore; Declares 3rd Interim Dividend of ₹4.30 per share appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

Cash & Cash Equivalent at Rs. 8,755 Cr (14% of the Net worth)

·         Volume growth of 17% YoY, at 16.5 Mn T, Highest ever cement sales Volume in a quarter.

·         EBITDA PMT at Rs 1,038, EBITDA margin at 18.4%.

·         Commissioned 200 MW Solar Power at Khavda, will lead to reduction in power cost in upcoming quarters.

·         Addition of 631 Mn MT Limestone reserves during Dec’24 Qtr. taking total reserves to 8.3 Bn MT.

·         Net Zero commitment – Partnered with Finland-based Coolbrook to leverage zero-carbon rotodynamic heating technology.

·         Capacity to hit 104 MTPA by Q4 FY’25, 118 MTPA by FY’26 and 140 MTPA by FY’28

·         EPS of Rs 8.59 for the quarter, up by Rs 4.72 YoY.

·         Orient Cement acquisition expected to be closed in Q4 FY’25. Merger of Penna and Sanghi under progress.

Bengaluru, 29 January 2025: Ambuja Cements Limited, the cement and building materials company of the diversified Adani Portfolio, today announced sustainable financial results for Q3 ended December 31, 2024, and nine months (9M) of FY’25. The significant boost in efficiencies, enhanced market presence and cost leadership aligned with Group synergies have been the growth drivers for the cement business. Efficiency investments & digitisation initiatives have started to yield results. The Company remains committed to maintain its cost and market leadership in coming quarters. 

Mr. Ajay Kapur, Whole Time Director & CEO of Ambuja Cements Limited, stated “We are pleased to report a quarter of sustainable performance, aligned with our growth plan. With focus on innovation, digitisation, customer satisfaction, and ESG, our vision drives our expansion into new geographies. Our strategic acquisitions have significantly increased our capacity and market presence.  This will be dove-tailed with our ongoing expansion projects, delivering exceptional value for our stakeholders and propelling us towards achieving over 104 MTPA capacity by Q4 FY’25 and 118 MTPA by FY 26. 

Cost Leadership / Operational Highlights 

·         Efficiency initiatives and investments across all operational areas have shown healthy improvements reinforcing Ambuja’s cost leadership.

·         Increased use of low cost Imported Petcoke and efforts to reduce cost of domestic coal (e-auction coal, efficient logistics, group synergies) has helped to reduce kiln fuel cost by 10% from Rs. 1.84 to Rs. 1.66 per ’000 Kcal.

·         WHRS power share increased by 4.0 pp from 12.6% to 16.6%, Solar power mix increased by 1.9 pp from 2.5% to 4.4%, taking the green power share up by 5.7 pp to 21.5%, clear road map & investment commitments to achieve 60% green power by FY 28.

·         Logistics costs reduced by 5% @Rs 1,228/ton, driven by efficiency improvement journey (overall lead reducing by 4 km, direct dispatch up by 7 pp @57%). Through various freight negotiation initiatives, road PTPK has decreased by 2% YOY. This is going to be further reduced with roll out of initiatives viz. wheeler rationalisations, BCFC rakes etc.

·         Ambuja has deployed 5 BCFCM rakes against the order for 26 BCFCM rakes placed earlier for transportation of Dry fly ash. Planned to place further orders of 32 BCFCM rakes to cater the rising fly ash demand of existing and upcoming plants.

·         Supply from Krishnapatnam Grinding Unit to Cochin and Mangalore market through sea route has commenced and this will help in optimizing freight costs and boost profitability.

·         Acquired assets like Sanghi, Asian and Penna doing well. Penna plants operations getting stabilised and the Clinker capacity utilisation has gone up to ~85%.

Cost reduction initiatives for fuel, fly ash, logistics and overall man-power productivity, will help to achieve cost of Rs. 3,650 PMT by FY 2028, will help to boost EBITDA margins. 

Financial Highlights (Consolidated) 

·         Higher volume along with improved operational parameters resulted in growth in all business parameters.

·         EBITDA PMT @ Rs. 1,038, EBITDA Margin at 18.4%.

·         Net worth increased by Rs. 2,619 Cr during the quarter and stands at Rs. 62,535 Cr, Company remains debt free & continues to maintain the rating Crisil AAA (stable) / Crisil A1+.

·         The Cash & Cash Equivalent stands at Rs. 8,755 Cr (14% of the Net worth) enables accelerated growth in future.

·         For Ambuja (consolidated), business level working capital stands at 31 days, reflecting agility in unblocking the funds in inventory and receivables. 

Financial Performance for the Quarter ended December 31, 2024: 

    * Including Reversal of Income tax provision of earlier years Rs. 829 Cr against which refund has been received 

Financial Performance for the nine months ended December 31, 2024: 

ESG Updates

·         Commissioned 200 MW Solar Power at Khavda as part of the 1000 MW Solar/Wind capex initiative.  Balance targeted to be achieved by June 2026.  Will boost cost reduction program.

·         Ambuja Cements enters into strategic partnership with Finland-based Coolbrook to implement its proprietary RotoDynamic Heater™ (RDH™) technology. This will significantly reduce fossil fuel dependency by harnessing Renewable Electricity for zero carbon high-temperature process heating. This will advance company’s leadership in driving decarbonisation across its cement manufacturing process.

·         Committed to Net Zero by 2050, with Ambuja Cements and ACC being the only 2 cement companies in India undergoing Net Zero target validation from SBTi.

·         Undertook noteworthy initiatives on water conservation, circular economy, Thermal Substitution, tree plantation along with high share of blended cement in product mix.

·         Digital initiatives in ESG to constantly measure and monitor performance against goals and targets.

·         Ambuja and ACC together created societal value for over 4.75 million people by contributing to fields like healthcare, education, employment, and sustainable livelihoods. 

Branding

·         Partnered with the Gujarat Giants in Pro Kabaddi League Season 11, one of India’s premier sports leagues.

·         ACC Certified Technology implemented at 37,214 customer sites, making their homes stronger.

·         Trained 10,300+ Contractors under various skill upgradation workshops with 3,300+ plant visits, aimed at deeper understanding of our products.

·         Various knowledge sharing technical events conducted for 6,300+ construction professionals.

·         Launched thematic Ad films for Durga Puja and Diwali reflecting the festive fervour our customers and partners.

Digitalisation

·         Launched ‘Rewards Connect’, a loyalty rewards portal, enabling pan-India online reward point redemption for contractors.

·         Deployed OT Security Monitoring solution for real-time monitoring of OT systems strengthening cybersecurity.

·         Completed Asia’s largest legacy SAP upgrade to Suite on HANA.

·         Implemented Electronic Proof of Delivery system, improving invoicing efficiency and reducing processing/documentation cost.

Outlook

Improved consumption demand in housing and infrastructure segments, and increased government spending are poised to reverse the tepid 1.5-2% cement demand growth during H1 FY’25. This demand is expected to grow by 4-5% in FY’25, further supported by the pro-infra and housing Budget 2025. Ambuja Cements is well-positioned to benefit from these trends. The anticipated rebound in demand, supported by government initiatives, is likely to enhance cement sector performance in the coming quarters.  Ambuja Cements will continue to grow at a faster speed than the industry.

 Achievements

·         Golden Peacock Award 2024 for showcasing excellence in ESG initiatives at IOD’s Annual Global Convention on Corporate Governance and Sustainability in London, UK.

·         CII SCALE Award 2024 for Excellence in Logistics.

·         Gold at the Arogya World Healthy Workplace Awards 2024.

The post Ambuja Cements’ PAT grows more than double YoY in Q3 FY’25 appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

Bengaluru: Suzlon Group, India’s largest renewable energy solutions provider, reported its third-quarter results for the financial year 2024-25 (Q3 FY25) ending on 31st December 2024.

Girish Tanti, Vice Chairman, Suzlon Group, said, “We are building a future-ready business by fortifying our core strategic pillars: cultivating strategic talent, leveraging next-generation technology, amplifying customer-centricity, and expanding operational capacity. Our sustained focus on these priorities drives consistent growth, performance, and long-term profitability. One emerging trend fuelling our growth is our strategic emphasis on Commercial & Industrial (C&I) and Public Sector Undertaking (PSU) customers. As these organisations prioritise sustainability and renewable energy, we’re delivering reliable, affordable solutions that power their operations. This strategic shift is driving demand, positioning Suzlon as a trusted partner for businesses pursuing green energy ambitions and catalysing growth in the renewable energy sector.”

JP Chalasani, Chief Executive Officer, Suzlon Group, said, “We are experiencing consistent quarter-on-quarter growth, with each of our businesses operating as strong, independent entities driving performance. Our manufacturing capacity expansion in India is progressing as planned to fulfill our record-high order book of 5.5 GW. With our ramp-up strategy on track and operational preparedness at optimal levels, we can sustain momentum, create long-term value for our stakeholders, and play a pivotal role in advancing India’s renewable energy ambitions.”

Himanshu Mody, Chief Financial Officer, Suzlon Group, said, “Our focus in Q3 FY25 was execution, which is visible in our financial performance, marked by significant profit growth driven by volume and margin expansion and enhanced operating leverage. Strong stakeholder support has been instrumental in accelerating our ramp-up efforts. With a robust order book, market-leading products, ample working capital, and a well-established supply chain, we are strategically aligned to seize emerging opportunities and further strengthen our market leadership.” 

Suzlon Group Q3 FY25 Results at a glance (consolidated):  

 (₹ Cr.)

Product Innovation 

S144 continues to dominate the Indian wind market and has received a very strong customer response. It currently accounts for 92% (~5 GW) of our overall order book. We are on track with the production ramp-up of the technology, and in this quarter, we achieved a key milestone in delivering the 300^th S144 wind turbine. 

Human Resources 

Suzlon’s innovative partnership model with the government is revolutionising the wind energy sector by addressing a critical talent development gap. This strategic collaboration aims to upskill the workforce and nurture industry-ready talent, ultimately supporting India’s transition to a sustainable energy future. A significant milestone in this initiative is Suzlon’s Memorandum of Understanding (MoU) with the Andhra Pradesh Government, which will launch India’s largest green skill program. This program is expected to create approximately 12,000 green careers, empowering individuals with the necessary skills to bridge the employability gap. By fostering a skilled workforce, Suzlon is not only contributing to India’s sustainable energy goals but also enhancing the country’s competitiveness in the global renewable energy market.

Wind Turbine Generator (WTG) Manufacturing 

We are making big strides in expanding our manufacturing capacity to meet the growing order book. We have revamped our Daman and Puducherry Nacelle manufacturing facilities and have reached 4.5 GW annual capacity. Two additional production lines are being added at our Ratlam and Jaisalmer facilities to scale operations efficiently. We continue to strengthen our order pipeline with a healthy mix of new and repeat customers, securing three large orders and reaffirming partnerships with key clients like Jindal Renewables and Torrent. These achievements reinforce market confidence in Suzlon’s capabilities and leadership in the renewable energy sector. 

OMS 

The OMS business remains a significant growth driver for the Suzlon Group, consistently outperforming expectations. Safety is deeply embedded in our culture, and we remain committed to investing in proactive initiatives. Currently, Suzlon is collaborating with leading consultants to enhance field safety and optimise operational efficiency, ensuring long-term sustainable growth. 

Awards and Recognition 

• CRISIL Ratings has upgraded Suzlon’s credit rating to ‘CRISIL A’ from ‘CRISIL A-’ with Positive Outlook for the second time in 2024, reflecting the company’s strong performance and enhanced profitability.

• Suzlon Group has won GEEF’s Global Sustainability Award 2024 for Sustainability Excellence in Renewable Energy (Power Sector).

• Suzlon Global Services Ltd (SGSL) has been honoured with the ‘Great Indian Renewable Energy Company of the Year’ award at the 3rd Sustainability Conclave, recognising its excellence in sustainable energy practices.

• SGSL has also received the ‘Gold Award-Green Practices’ under the Service Category at the 3rd CII-Northern Region Green Practices Award by the Confederation of Indian Industry (CII), further reinforcing its commitment to environmental stewardship.

• Suzlon’s WTG Manufacturing Businesses have been honoured with six prestigious recognitions at the Frost & Sullivan IMEA Awards for outstanding performance across various units, including WTG Unit Daman, Nacelle Cover Unit (Daman), Control Panel Unit (Daman), Rotor Blade Unit (Bhuj), Tubular Tower Unit (Gandhidham), and the Corporate Gold Award in the Engineering Sector.

The post Q3 FY25 Results: Continued Profit Growth with 91% YoY increase to ₹388 Crores  appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.